<DOC>
	<DOC>NCT00095719</DOC>
	<brief_summary>The purpose of this trial is to test the safety &amp; tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.</brief_summary>
	<brief_title>Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Acute agitation in Patients with a DSMIV diagnosis of Alzheimer's, vascular or mixed Dementia. Current DSMIV Axis 1 diagnosis other than Alzheimer's, vascular or mixed Dementia.</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Acute agitation in patients diagnosed with Dementia</keyword>
</DOC>